The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
A preliminary study to determine the safety and efficacy of intravitreal aflibercept
injection in patients with persistent central serous chorioretinopathy.